Literature DB >> 8566117

L-alpha-aminoadipic acid as a regulator of kynurenic acid production in the hippocampus: a microdialysis study in freely moving rats.

H Q Wu1, U Ungerstedt, R Schwarcz.   

Abstract

L-alpha-Aminoadipic acid is a lysine metabolite with neuroexcitatory properties, and has previously been shown to inhibit the production of the broad spectrum excitatory amino acid receptor antagonist kynurenic acid in brain tissue slices. The effects of L-alpha-aminoadipic acid on the levels of extracellular kynurenic acid were now studied by microdialysis in the dorsal hippocampus of freely moving rats. Application of L-alpha-aminoadipic acid through the microdialysis probe dose dependently decreased both the concentration of endogenous kynurenic acid and of kynurenic acid which was produced de novo from its bioprecursor L-kynurenine (500 microM applied through the probe). 500 microM L-alpha-aminoadipic acid lowered the kynurenic acid concentration in the dialysate by 47% and 28% with and without precursor loading, respectively, whereas D-alpha-aminoadipic acid was without effect. Co-administration of 500 microM L-alpha-aminoadipic acid with 50 microM veratridine, which by itself produces a substantial decrease in the levels of extracellular kynurenic acid, did not result in a further reduction in kynurenic acid concentrations. Extensive neuronal degeneration caused by an intrahippocampal injection of quinolinic acid (120 nmol) did not interfere with the effect of L-alpha-aminoadipic acid. Taken together, these data suggest that the effect of L-alpha-aminoadipic acid on extracellular kynurenic acid levels is likely due to its direct action on astrocytes, which are known to harbor kynurenic acid's biosynthetic enzyme, kynurenine aminotransferase. L-alpha-Aminoadipic acid may modulate kynurenic acid function in the brain and thus play a role in the pathogenesis of neurodegenerative and seizure disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566117     DOI: 10.1016/0014-2999(95)00224-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.

Authors:  Joanne H Huang; Shaunna S Berkovitch; Jonathan Iaconelli; Bradley Watmuff; Hyoungjun Park; Shrikanta Chattopadhyay; Donna McPhie; Dost Öngür; Bruce M Cohen; Clary B Clish; Rakesh Karmacharya
Journal:  Mol Neuropsychiatry       Date:  2016-06-24

2.  Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cells.

Authors:  Eszter Lajkó; Bernadett Tuka; Ferenc Fülöp; István Krizbai; József Toldi; Kálmán Magyar; László Vécsei; László Kőhidai
Journal:  J Neural Transm (Vienna)       Date:  2018-01-13       Impact factor: 3.575

3.  Multiomic profiling of iron-deficient infant monkeys reveals alterations in neurologically important biochemicals in serum and cerebrospinal fluid before the onset of anemia.

Authors:  Brian J Sandri; Jonathan Kim; Gabriele R Lubach; Eric F Lock; Candace Guerrero; LeeAnn Higgins; Todd W Markowski; Pamela J Kling; Michael K Georgieff; Christopher L Coe; Raghavendra B Rao
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-03-10       Impact factor: 3.210

4.  Metabolic profile associated with distinct behavioral coping strategies of 129Sv and Bl6 mice in repeated motility test.

Authors:  Jane Narvik; Taavi Vanaveski; Jürgen Innos; Mari-Anne Philips; Aigar Ottas; Liina Haring; Mihkel Zilmer; Eero Vasar
Journal:  Sci Rep       Date:  2018-02-21       Impact factor: 4.379

5.  NMR-based plasma metabolic profiling in patients with unstable angina.

Authors:  Mohammad PouralijanAmiri; Maryam Khoshkam; Reza Madadi; Koorosh Kamali; Ghassem Faghanzadeh Ganji; Reza Salek; Ali Ramazani
Journal:  Iran J Basic Med Sci       Date:  2020-03       Impact factor: 2.699

6.  Repeated Administration of D-Amphetamine Induces Distinct Alterations in Behavior and Metabolite Levels in 129Sv and Bl6 Mouse Strains.

Authors:  Taavi Vanaveski; Jane Narvik; Jürgen Innos; Mari-Anne Philips; Aigar Ottas; Mario Plaas; Liina Haring; Mihkel Zilmer; Eero Vasar
Journal:  Front Neurosci       Date:  2018-06-12       Impact factor: 4.677

7.  Metabolic Signatures Differentiate Rett Syndrome From Unaffected Siblings.

Authors:  Jeffrey L Neul; Steven A Skinner; Fran Annese; Jane Lane; Peter Heydemann; Mary Jones; Walter E Kaufmann; Daniel G Glaze; Alan K Percy
Journal:  Front Integr Neurosci       Date:  2020-02-25

8.  Inhibition of astrocyte metabolism is not the primary mechanism for anaesthetic hypnosis.

Authors:  Logan J Voss; Martyn G Harvey; James W Sleigh
Journal:  Springerplus       Date:  2016-07-11

9.  Treatment With Lipopolysaccharide Induces Distinct Changes in Metabolite Profile and Body Weight in 129Sv and Bl6 Mouse Strains.

Authors:  Maria Piirsalu; Egon Taalberg; Kersti Lilleväli; Li Tian; Mihkel Zilmer; Eero Vasar
Journal:  Front Pharmacol       Date:  2020-03-27       Impact factor: 5.810

10.  Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient Cells.

Authors:  Rudolf Hergesheimer; Débora Lanznaster; Jérôme Bourgeais; Olivier Hérault; Patrick Vourc'h; Christian R Andres; Philippe Corcia; Hélène Blasco
Journal:  Cells       Date:  2020-09-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.